BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17086809)

  • 1. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USA hCG reference service, 10-year report.
    Cole LA; Laidler LL; Muller CY
    Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R; Ben-David Y
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
    Cole LA; Muller CY
    Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
    Cole LA; Kohorn EI
    J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S; Sasaki Y; Iino K
    J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases.
    Hwang D; Hancock BW
    J Reprod Med; 2004 Jul; 49(7):559-62. PubMed ID: 15305828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
    Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
    J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the clinical laboratory detection of gestational trophoblastic disease.
    Seki K; Matsui H; Sekiya S
    Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
    Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
    J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53.
    Soper JT; Mutch DG; Schink JC;
    Gynecol Oncol; 2004 Jun; 93(3):575-85. PubMed ID: 15196847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.